1)Inoue K, Makuuchi M, Takayama T, et al:Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 127:498-505, 2000
2)Shimada K, Sano T, Nara S, et al:Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery 145:411-416, 2009
3)Morine Y, Shimada M, Utsunomiya T, et al:Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42:147-151, 2012
4)Ohtsuka M, Ito H, Kimura F, et al:Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525-1531, 2002
5)北爪伸仁,奥平雅彦:肝内外リンパ流路.肝胆膵30:447-451, 1995
6)Comparini L:Lymph vessels of the liver in man. Microscopic morphology and histopography. Angiologica 6:262-274, 1969
7)日本肝癌研究会(編):臨床・病理 原発性肝癌取扱い規約,第5版補訂版.金原出版,2009
8)日本肝胆膵外科学会(編):臨床・病理 胆道癌取扱い規約,第6版.金原出版,2013
9)Edge SB, Byrd DR, Compton CC, et al(eds);American Joint Committee on Cancer:AJCC Cancer Staging Manual, 7th ed. New York, Springer, 2010
10)Shimada M, Yamashita Y, Aishima S, et al:Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463-1466, 2001
11)Miwa S, Miyagawa S, Kobayashi A, et al:Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893-900, 2006
12)Weber S, Jarnagin WR, Klimstra D, et al:Intrahepatic cholangiocarcinoma:resectability, recurrence pattern, and outcomes. J Am Coll Surg 193:384-391, 2001